Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2014 | 10-2013 | 10-2012 | 10-2011 | 10-2010 | |
| Sales | 373 | 595 | 603 | 573 | 283 |
| Cost of Goods | 313 | 509 | 563 | 464 | 213 |
| Gross Profit | 61 | 86 | 40 | 110 | 69 |
| Operating Expenses | 231 | 113 | 187 | 96 | 213 |
| Operating Income | -170 | -27 | -147 | 14 | -144 |
| Interest Expense | 2 | 1 | 9 | 17 | 15 |
| Other Income | 204 | -165 | 68 | 3 | 159 |
| Pre-tax Income | 32 | -193 | -88 | N/A | N/A |
| Net Income Continuous | 32 | -193 | -88 | -2 | -160 |
| Net Income | $32 | $-193 | $-88 | $-2 | $-160 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $34 | $-192 | $-78 | $14 | $-144 |